Wordt geladen...
Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
Histone deacetylase inhibitors (HDACi) have been approved and achieved success in hematologic malignancies. But its application in solid tumors still confronts big challenges and is hampered by low treatment efficacy. Nanotechnology has been widely applied in cancer therapy, and nanomedicine could i...
Bewaard in:
| Gepubliceerd in: | Front Cell Dev Biol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7284110/ https://ncbi.nlm.nih.gov/pubmed/32582697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00400 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|